Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Low-dose oral minoxidil is increasingly used by dermatologists in the UK and Ireland to treat various hair loss conditions.

AMF initially inhibits but later promotes citrus root hair growth by regulating auxin levels.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

Ivarmacitinib may effectively treat complex atopic dermatitis and related hair loss.

Oral JAK inhibitors effectively regrow hair in alopecia areata with a good safety profile.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Topical JAK inhibitors may help treat some skin conditions but need more research.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

JMJD3 and NF-κB activate Notch1, which is essential for skin cell movement and wound healing.

Keratin K6irs is a marker for the inner root sheath of hair follicles in mice and humans.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

Upadacitinib may effectively treat alopecia areata without side effects.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.